INM
InMed·NASDAQ
--
--(--)
--
--(--)
INM fundamentals
During Q2 2026, InMed (INM) reported revenue of 820.19K, a YoY change of -26.22%. Net income was -2.03M, a YoY change of 21.23%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | Q1,2026 | Q2,2026 | TTM |
|---|
Start Date | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | -- |
Revenue | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 265.09K -- | 309.58K -- | 514.76K -- | 320.79K -- | 469.78K +77.22% | 1.03M +233.97% | 2.31M +348.96% | 901.86K +181.14% | 1.24M +163.99% | 1.17M +13.41% | 1.28M -44.48% | 1.26M +40.23% | 1.11M -10.36% | 1.26M +7.59% | 1.30M +1.69% | 1.12M -11.43% | 820.19K -26.22% | 4.51M -- |
Sales and Services Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 265.09K -- | 309.58K -- | 514.76K -- | 320.79K -- | 469.78K +77.22% | 1.03M +233.97% | 2.31M +348.96% | 901.86K +181.14% | 1.24M +163.99% | 1.17M +13.41% | 1.28M -44.48% | 1.26M +40.23% | 1.11M -10.36% | 1.26M +7.59% | 1.30M +1.69% | 1.12M -11.43% | 820.19K -26.22% | 4.51M -- |
Cost of Revenue | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 153.54K -- | 127.31K -- | 265.04K -- | 811.81K -- | 338.62K +120.55% | 841.41K +560.93% | 740.68K +179.46% | 880.62K +8.48% | 916.06K +170.53% | 883.14K +4.96% | 817.00K +10.30% | 771.23K -12.42% | 650.81K -28.96% | 1.09M +22.96% | 728.06K -10.89% | 716.96K -7.04% | 635.99K -2.28% | 3.17M -- |
Cost of Goods and Services | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 545.89K -- | -- -- | -- -- | -- -- | 2.73M +400.56% | 880.62K -- | 916.06K -- | 883.14K -- | 817.00K -70.10% | 771.23K -12.42% | 650.81K -28.96% | 1.09M +22.96% | 728.06K -10.89% | 716.96K -7.04% | 635.99K -2.28% | 3.17M -- |
Gross Profit | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 111.56K -- | 182.28K -- | 249.71K -- | -491.02K -- | 131.16K +17.58% | 192.51K +5.61% | 1.57M +528.87% | 21.24K +104.33% | 324.14K +147.13% | 289.46K +50.36% | 466.07K -70.32% | 493.41K +2222.82% | 460.89K +42.19% | 175.63K -39.33% | 576.65K +23.73% | 403.16K -18.29% | 184.19K -60.04% | 1.34M -- |
Operating Expenses | 2.50M -- | 3.10M -- | 2.88M -- | 2.51M -- | 2.20M -11.66% | 1.56M -49.66% | 1.56M -45.69% | 1.93M -22.84% | 3.13M +42.16% | 3.31M +111.93% | 2.89M +84.96% | 4.42M +128.69% | 3.72M +18.77% | 6.77M +104.75% | 3.08M +6.65% | 2.35M -46.99% | 2.34M -37.01% | 2.01M -70.35% | 2.65M -14.24% | 2.03M -13.48% | 2.09M -11.04% | 2.48M +23.30% | 2.25M -15.04% | 2.67M +31.45% | 2.29M +9.84% | 2.42M -2.27% | 2.17M -3.60% | 2.30M -13.58% | 9.18M -- |
Selling, General and Administrative Expenses | 1.07M -- | 1.05M -- | 917.74K -- | 899.98K -- | 929.40K -12.94% | 592.48K -43.71% | 652.77K -28.87% | 996.37K +10.71% | 1.36M +46.45% | 1.59M +168.35% | 1.40M +114.69% | 1.89M +89.35% | 1.97M +44.61% | 1.80M +12.98% | 1.61M +14.85% | 1.51M -19.75% | 1.46M -25.65% | 1.46M -18.56% | 1.35M -15.90% | 1.42M -6.26% | 1.43M -2.36% | 1.82M +24.15% | 1.55M +14.33% | 1.77M +24.86% | 1.38M -3.33% | 2.31M +26.97% | 1.59M +2.43% | 1.67M -5.51% | 6.95M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | 3.23M -- | -- -- | -- -- | -- -- | 4.48M +38.80% | -- -- | -- -- | -- -- | 6.87M +53.30% | -- -- | -- -- | -- -- | 5.85M -14.85% | 1.30M -- | 1.36M -- | 1.37M -- | 1.76M -69.88% | 1.49M +14.96% | 1.72M +26.01% | 1.33M -3.28% | 2.25M +27.92% | 1.53M +2.62% | 1.62M -5.68% | 6.74M -- |
Research and Development Expenses | 1.43M -- | 2.05M -- | 1.96M -- | 1.61M -- | 1.27M -10.71% | 967.61K -52.72% | 911.16K -53.56% | 937.95K -41.63% | 1.77M +39.04% | 1.72M +77.38% | 1.49M +63.67% | 2.54M +170.49% | 1.75M -1.07% | 1.50M -12.56% | 1.38M -7.55% | 851.36K -66.44% | 878.30K -49.91% | 623.74K -58.44% | 1.29M -6.28% | 609.79K -28.37% | 656.76K -25.22% | 658.87K +5.63% | 700.14K -45.81% | 895.18K +46.80% | 909.65K +38.51% | 112.72K -82.89% | 581.61K -16.93% | 630.64K -29.55% | 2.23M -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 3.47M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 96.79K -- | -20.24K -- | 2.73K -- | -79.29K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -2.50M -- | -3.10M -- | -2.88M -- | -2.51M -- | -2.20M +11.66% | -1.56M +49.66% | -1.56M +45.69% | -1.93M +22.84% | -3.13M -42.16% | -3.31M -111.93% | -2.89M -84.96% | -4.31M -122.93% | -3.54M -12.95% | -6.52M -97.20% | -3.58M -23.62% | -2.21M +48.66% | -2.15M +39.20% | -436.98K +93.30% | -2.62M +26.61% | -1.70M +22.99% | -1.80M +16.53% | -2.01M -359.75% | -1.75M +33.16% | -2.21M -29.41% | -2.12M -17.77% | -1.84M +8.31% | -1.76M -0.54% | -2.12M +3.88% | -7.84M -- |
Non-Operating Income (Loss) | 27.01K -- | 21.50K -- | 74.34K -- | 13.31K -- | 180.26K +567.40% | -56.20K -361.31% | -35.15K -147.29% | -309.46K -2424.52% | 32.26K -82.10% | 47.55K +184.61% | -78.96K -124.62% | 29.28K +109.46% | 63.96K +98.24% | -1.35M -2939.34% | 72.59K +191.92% | 115.80K +295.43% | 155.50K +143.12% | 100.38K +107.44% | 87.59K +20.66% | 226.66K +95.74% | 73.30K -52.86% | 78.44K -21.86% | 76.40K -12.77% | -368.77K -262.70% | -5.60K -107.64% | 53.82K -31.38% | 36.77K -51.87% | 92.52K +125.09% | 177.51K -- |
Gain (Loss) on Other Investment | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 242.63K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gain (Loss) on Foreign Currency Exchange | -- -- | -- -- | -- -- | -- -- | -- -- | 82.19K -- | -- -- | -- -- | -- -- | -163.10K -298.45% | -- -- | -- -- | -- -- | -117.55K +27.93% | -- -- | -- -- | -- -- | -48.17K +59.02% | -48.46K -- | 59.90K -- | -48.16K -- | -25.20K +47.68% | 19.31K +139.85% | -47.75K -179.73% | -22.16K +53.97% | 22.14K +187.83% | -56.99K -395.15% | 18.14K +137.98% | -38.89K -- |
Other Non-Operating Income (Loss) | -54.89K -- | -47.54K -- | 15.93K -- | -27.18K -- | 153.93K +380.42% | -142.68K -200.09% | -39.50K -347.92% | 47.84K +275.98% | 32.26K -79.04% | -48.00K +66.36% | -78.96K -99.91% | 29.28K -38.78% | 63.96K +98.24% | -1.33M -2668.12% | 72.59K +191.92% | 115.80K +295.43% | 155.50K +143.12% | -343.88K +74.12% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Interest Expense | -81.90K -- | -69.05K -- | -58.41K -- | -40.49K -- | -26.33K +67.85% | -4.29K +93.78% | -4.34K +92.56% | 357.30K +982.33% | -- -- | -16.02K -272.92% | -- -- | -- -- | -- -- | -96.09K -499.93% | -- -- | -- -- | -- -- | -492.44K -412.48% | -136.04K -- | -166.76K -- | -121.46K -- | -103.64K +78.95% | -57.09K +58.03% | 321.01K +292.50% | -16.57K +86.36% | -31.69K +69.43% | -93.77K -64.23% | -74.38K -123.17% | -216.40K -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 360.35K -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | -- -- | 351.55K -- | 0 -- | 20.00K -- | -- -- | 0 -100.00% | -- -- |
Interest Income | 81.90K -- | 69.05K -- | 58.41K -- | 40.49K -- | 26.33K -67.85% | 4.29K -93.78% | 4.34K -92.56% | 3.05K -92.47% | -- -- | 16.02K +272.92% | -- -- | -- -- | -- -- | 96.09K +499.93% | -- -- | -- -- | -- -- | 492.44K +412.48% | 136.04K -- | 166.76K -- | 121.46K -- | 103.64K -78.95% | 57.09K -58.03% | 30.54K -81.69% | 16.57K -86.36% | 51.69K -50.13% | 93.77K +64.23% | 74.38K +143.58% | 236.40K -- |
Pretax Income From Continuing Operations | -2.47M -- | -3.08M -- | -2.81M -- | -2.49M -- | -2.02M +18.00% | -1.62M +47.48% | -1.60M +43.00% | -2.24M +10.01% | -3.10M -53.23% | -3.26M -101.62% | -2.97M -85.83% | -4.28M -90.87% | -3.48M -12.06% | -7.87M -141.50% | -3.50M -17.90% | -2.10M +51.01% | -2.00M +42.56% | -336.59K +95.72% | -2.54M +27.59% | -1.48M +29.55% | -1.72M +13.70% | -1.93M -473.57% | -1.68M +33.86% | -2.58M -74.20% | -2.12M -23.10% | -1.79M +7.37% | -1.73M -2.92% | -2.03M +21.23% | -7.66M -- |
Income Tax Expense | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | 6.80K -- | 3.00K -- | 1.50K -- | 1.80K -- | -- -- | -- -- | -- -- | 7.10K +294.44% | 0 -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | -- -- |
Net Income | -2.47M -- | -3.08M -- | -2.81M -- | -2.49M -- | -2.02M +18.00% | -1.62M +47.48% | -1.60M +43.00% | -2.24M +10.01% | -3.10M -53.23% | -3.26M -101.62% | -2.97M -85.83% | -4.28M -90.87% | -3.48M -12.06% | -7.87M -141.50% | -3.51M -18.12% | -2.10M +50.94% | -2.00M +42.52% | -338.39K +95.70% | -2.54M +27.73% | -1.48M +29.65% | -1.72M +13.77% | -1.94M -472.61% | -1.68M +33.86% | -2.58M -74.20% | -2.12M -23.10% | -1.79M +7.71% | -1.73M -2.92% | -2.03M +21.23% | -7.66M -- |
Net Income Attributable to Owners of the Company | -2.47M -- | -3.08M -- | -2.81M -- | -2.49M -- | -2.02M +18.00% | -1.62M +47.48% | -1.60M +43.00% | -2.24M +10.01% | -3.10M -53.23% | -3.26M -101.62% | -2.97M -85.83% | -4.28M -90.87% | -3.48M -12.06% | -7.87M -141.50% | -3.51M -18.12% | -2.10M +50.94% | -2.00M +42.52% | -338.39K +95.70% | -2.54M +27.73% | -1.48M +29.65% | -1.72M +13.77% | -1.94M -472.61% | -1.68M +33.86% | -2.58M -74.20% | -2.12M -23.10% | -1.79M +7.71% | -1.73M -2.92% | -2.03M +21.23% | -7.66M -- |
Net Income Attributable to Common Stockholders | -2.47M -- | -3.08M -- | -2.81M -- | -2.49M -- | -2.02M +18.00% | -1.62M +47.48% | -1.60M +43.00% | -2.24M +10.01% | -3.10M -53.23% | -3.26M -101.62% | -2.97M -85.83% | -4.28M -90.87% | -3.48M -12.06% | -7.87M -141.50% | -3.51M -18.12% | -2.10M +50.94% | -2.00M +42.52% | -338.39K +95.70% | -2.54M +27.73% | -1.48M +29.65% | -1.72M +13.77% | -1.94M -472.61% | -1.68M +33.86% | -2.58M -74.20% | -2.12M -23.10% | -1.79M +7.71% | -1.73M -2.92% | -2.03M +21.23% | -7.66M -- |
Other Comprehensive Income | 384.52K -- | 307.46K -- | -318.48K -- | 350.15K -- | -717.51K -286.60% | 266.00K -13.49% | 129.40K +140.63% | 301.04K -14.03% | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -2.08M -- | -2.77M -- | -3.12M -- | -2.14M -- | -2.74M -31.57% | -1.35M +51.26% | -1.47M +52.95% | -1.94M +9.36% | -3.10M -13.13% | -3.26M -141.34% | -2.97M -102.19% | -4.28M -120.45% | -3.48M -12.06% | -7.87M -141.50% | -3.51M -18.12% | -2.10M +50.94% | -2.00M +42.52% | -338.39K +95.70% | -2.54M +27.73% | -- -- | -- -- | -7.68M -2168.25% | -- -- | -- -- | -- -- | -8.16M -6.34% | -- -- | -- -- | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -2.08M -- | -2.77M -- | -3.12M -- | -2.14M -- | -2.74M -31.57% | -1.35M +51.26% | -1.47M +52.95% | -1.94M +9.36% | -3.10M -13.13% | -3.26M -141.34% | -2.97M -102.19% | -4.28M -120.45% | -3.48M -12.06% | 10.73M +429.27% | -3.51M -18.12% | -2.10M +50.94% | -2.00M +42.52% | 7.61M -29.09% | -- -- | -- -- | -- -- | -7.68M -200.87% | -- -- | -- -- | -- -- | -8.16M -6.34% | -- -- | -- -- | -- -- |
Basic EPS | -0.01 -- | -- -- | -0.54 -- | -0.48 -- | -0.39 -3800.00% | -- -- | -0.31 +42.59% | -0.37 +22.92% | -0.41 -5.13% | -0.4 -- | -6.17 -1890.32% | -7.73 -1989.19% | -6.14 -1397.56% | -13.04 -3160.00% | -4.06 +34.20% | -0.91 +88.23% | -0.6 +90.23% | -0.1 +99.23% | -15.24 -275.37% | -3.71 -307.69% | -3.58 -496.67% | -0.22 -120.00% | -2.71 +82.22% | -3.64 +1.89% | -1.94 +45.81% | -0.89 -304.55% | -0.44 +83.76% | -0.51 +85.99% | -3.78 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -15.24 -- | -3.71 -- | -3.58 -- | -- -- | -2.71 +82.22% | -3.64 +1.89% | -1.94 +45.81% | -- -- | -0.44 +83.76% | -0.51 +85.99% | -- -- |
Diluted EPS | -0.01 -- | -- -- | -0.54 -- | -0.48 -- | -0.39 -3800.00% | -- -- | -0.31 +42.59% | -0.37 +22.92% | -0.41 -5.13% | -- -- | -6.17 -1890.32% | -7.73 -1989.19% | -6.14 -1397.56% | -- -- | -4.06 +34.20% | -0.91 +88.23% | -0.6 +90.23% | -- -- | -15.24 -275.37% | -3.71 -307.69% | -3.58 -496.67% | -- -- | -2.71 +82.22% | -3.64 +1.89% | -1.94 +45.81% | -- -- | -0.44 +83.76% | -0.51 +85.99% | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -15.24 -- | -3.71 -- | -3.58 -- | -- -- | -2.71 +82.22% | -3.64 +1.89% | -1.94 +45.81% | -- -- | -0.44 +83.76% | -0.51 +85.99% | -- -- |
You can ask Aime
What were the key takeaways from InMed’s earnings call?What were the key takeaways from InMed's earnings call?What is InMed's latest dividend and current dividend yield?What is the revenue and EPS growth rate for InMed year over year?What does InMed do and what are its main business segments?What guidance did InMed's management provide for the next earnings period?What is InMed's gross profit margin?Did InMed beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
